Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1613 of 6351
-
New hope for Hard-to-Treat cancers? first human trial of AUBE00 begins
Disease control Recruiting nowThis is a first-in-human, Phase I, open-label, multicenter, multinational study, designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and anti-tumor activity of AUBE00 in patients with locally advanced or metastatic solid tu…
Phase 1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Stroke recovery from home: can video-based motor training outperform standard physical therapy?
Disease control Recruiting nowThis study aims to compare the effects of telerehabilitation based motor relearning program and telerehabilitation based conventional physical therapy on motor function and balance in stroke patients.
Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Ketamine KETTLE trial: a single infusion to ease anorexia distress
Symptom relief By invitation onlyThis is a single site, single dose clinical trial of intravenous (IV) ketamine for medically hospitalized adolescents and young adults with anorexia nervosa or atypical anorexia nervosa. Eating disorder symptoms will be measured pre- and post-ketamine infusion. Investigators hypo…
Phase 2 • Sponsor: Amanda Downey, MD • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New oral drug aims to tame severe eczema in teens
Disease control CompletedTo evaluate the population pharmacokinetic characteristics of QY201 Tablets in adolescent participants with moderate to severe atopic dermatitis (AD).
Phase 2 • Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Blindfold treadmill training shows promise for stroke rehab
Symptom relief Recruiting nowObjective: The aim of this study is to compare the efficiency of vision-obscured versus vision-retained treadmill gait training in subacute post-stroke patients. Methodology: Thirty-six patients with stroke (ischemic or hemorrhagic) less than six months old will be included and …
Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can a simple walk after stroke be safer with ultrasound guidance?
Knowledge-focused Recruiting nowPost-stroke mobilization remains a subject of ongoing debate. While early mobilization-particularly the first out-of-bed mobilization-has been associated with reduced systemic complications and earlier rehabilitation, it also carries potential risks, such as neurological deterior…
Sponsor: Unidade Local de Saúde de Coimbra, EPE • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Wearable tech aims to boost exercise and quality of life in cancer patients
Symptom relief Recruiting nowThis clinical trial compares the effect of an automated personalized physical activity intervention supported by wearable technology to standard of care on physical activity levels and quality of life in patients with stage II- IV ovarian, primary peritoneal, fallopian tube cance…
Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Blood test predicts which kids may benefit from autism drug
Symptom relief CompletedThe objective of this study is to learn if bumetanide could alleviate the clinical symptoms in children with autism spectrum disorder (ASD), who has been predicted as high responders to bumetanide via a cytokine-based predictive model. The Eligible ASD participants identified as …
Phase 2 • Sponsor: Fei Li • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Could a 2-Week radiation course replace longer treatment for skin cancer?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate if short-course radiation therapy (SCRT) can effectively treat high-risk cutaneous squamous cell carcinoma (cSCC) and if active surveillance is a safe alternative to radiation for moderate-risk cSCC in adults with head and neck cSCC …
Phase 2 • Sponsor: University of Vermont Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug cocktail targets Hard-to-Treat stomach cancer
Disease control Recruiting nowThe trial consists of Stage 1 (including dose escalation and dose expansion) and Stage 2 (proof-of-concept study). Among them, Stage 2 adopts a randomized, controlled, open-label, and multicenter design.
Phase 2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:06 UTC
-
Real-World check: can a new infusion drug ease advanced Parkinson's?
Disease control Recruiting nowParkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. This study will assess how effective Fos…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Sound wave helmet aims to boost brain cancer treatment
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and feasibility of focused ultrasound (FUS)-mediated blood-brain barrier (BBB) disruption using the Next Generation Dome Helmet (NGDH) in adults with glioblastoma (GBM) undergoing the maintenance phase of the standard "Stu…
Phase 1 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 26, 2026 17:44 UTC
-
New Four-Pronged antibody takes aim at lupus
Disease control Recruiting nowThis study is a randomized, controlled, phase I clinical study with safety, efficacy, and pharmacokinetic/pharmacodynamic characteristics in patients with systemic lupus erythematosus.
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a gentle Head-Zap calm the fear of mealtimes?
Symptom relief Recruiting nowThe study is to evaluate the feasibility of using a non-invasive brain stimulation device in a sample of inpatients with eating disorders (ED). The study will help researchers evaluate whether their device protocol is practical for eating disorder inpatients as a way to manage ea…
Sponsor: Rogers Behavioral Health • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New heart device aims to tame stubborn AFib
Disease control Recruiting nowThe ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters.
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Blood test may spot liver cancer risk years early in cirrhosis patients
Diagnosis Recruiting nowThis study aims to evaluate the role of the circulating epigenetic biomarker mSEPT9 in predicting the risk of hepatocellular carcinoma (HCC) in patients with cirrhosis. HCC is a primary liver cancer that frequently develops in individuals with cirrhosis, and early detection is cr…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Could 3 radiation doses beat 4 for cervical cancer?
Disease control Recruiting nowThis is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Could fasting help the immune system fight prostate cancer?
Knowledge-focused Recruiting nowActivating the immune system to kill cancer cells is a promising therapeutic strategy for some patients with cancer. Unfortunately, current immune-targeting treatments do not work for patients with prostate cancer. In animal models of cancer, fasting can reprogram the body's meta…
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
A gentle touch against frailty: acupoint massage and exercise put to the test in older adults
Symptom relief Recruiting nowThis study aims to explore the relationships between frailty, daily physical activity, sleep quality, and Traditional Chinese Medicine (TCM) constitutions among older adults in Taiwan. In the trial phase, a randomized controlled trial will be conducted specifically for pre-frail …
Sponsor: Tainan Hospital, Ministry of Health and Welfare • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New hope for Crohn's: experimental drug SAR442970 enters phase 2 trial
Disease control Recruiting nowThis is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Crohn's disease. The total s…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC